michigan glp-1 gi obstruction lawsuit The legal battle is heating up. Novo Nordisk sued Hims & Hers after the telehealth company announced plans to sell a compounded oral GLP-1 pill positioned as a lower-cost alternative to Ozempic GLP-1 Gastroparesis Lawsuit |

A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial led by a UTHealth Houston researcher.

Combining GLP-1 receptor agonists like Ozempic with inositol supplements is a strategy some patients explore for metabolic support

Now you've got the power to boost this powerful hormone* with our targeted, science-backed strains that help you produce more GLP-1 naturally

A GLP-1 plateau is when weight loss slows or stops during treatment with this medication

Available in 1 to 1000 μL

Therefore, further research is necessary to fully understand the potential of GLP-1 receptor agonists in providing comprehensive protection against complications related to T2DM.